Risperidone for the treatment of cocaine dependence: randomized, double-blind trial / John Grabowski en Journal of Clinical Psychopharmacology, Año 2000 - Vol. 20 - No. 3 (Junio)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2000 - Vol. 20 - No. 3 (Junio) . - pp. 305-310 Título : Risperidone for the treatment of cocaine dependence: randomized, double-blind trial Tipo de documento: texto impreso Autores: John Grabowski, Autor ; Howard Rhoades, Autor ; Peter Silverman, Autor Fecha de publicación: 2023 Artículo en la página: pp. 305-310 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Cocaína, Trastornos relacionados con la cocaína, Antagonistas de la dopamina, Abandono de pacientes, Psicoterapia, Risperidona Resumen: A partial blockade of the multiple actions of cocaine is one strategy by which cocaine dependence may be treated. Risperidone, a 5-hydroxytryptamine and dopamine D2 antagonist, is an atypical antipsychotic and was a candidate medication for the treatment of cocaine dependence. One hundred ninety-three cocaine-dependent subjects were enrolled in a 12-week, randomized, double-blind, placebo-controlled trial. Link: ./index.php?lvl=notice_display&id=31187 [artículo] Risperidone for the treatment of cocaine dependence: randomized, double-blind trial [texto impreso] / John Grabowski, Autor ; Howard Rhoades, Autor ; Peter Silverman, Autor . - 2023 . - pp. 305-310. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2000 - Vol. 20 - No. 3 (Junio) . - pp. 305-310 Palabras clave: Cocaína, Trastornos relacionados con la cocaína, Antagonistas de la dopamina, Abandono de pacientes, Psicoterapia, Risperidona Resumen: A partial blockade of the multiple actions of cocaine is one strategy by which cocaine dependence may be treated. Risperidone, a 5-hydroxytryptamine and dopamine D2 antagonist, is an atypical antipsychotic and was a candidate medication for the treatment of cocaine dependence. One hundred ninety-three cocaine-dependent subjects were enrolled in a 12-week, randomized, double-blind, placebo-controlled trial. Link: ./index.php?lvl=notice_display&id=31187

Risperidone for the treatment of cocaine dependence: randomized, double-blind trial / John Grabowski en Journal of Clinical Psychopharmacology, Año 2000 - Vol. 20 - No. 3 (Junio)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2000 - Vol. 20 - No. 3 (Junio) . - pp. 305-310 Título : Risperidone for the treatment of cocaine dependence: randomized, double-blind trial Tipo de documento: texto impreso Autores: John Grabowski, Autor ; Howard Rhoades, Autor ; Peter Silverman, Autor Fecha de publicación: 2023 Artículo en la página: pp. 305-310 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Cocaína, Trastornos relacionados con la cocaína, Antagonistas de la dopamina, Abandono de pacientes, Psicoterapia, Risperidona. Resumen: A partial blockade of the multiple actions of cocaine is one strategy by which cocaine dependence may be treated. Risperidone, a 5-hydroxytryptamine and dopamine D2 antagonist, is an atypical antipsychotic and was a candidate medication for the treatment of cocaine dependence. One hundred ninety-three cocaine-dependent subjects were enrolled in a 12-week, randomized, double-blind, placebo-controlled trial. Link: ./index.php?lvl=notice_display&id=31196 [artículo] Risperidone for the treatment of cocaine dependence: randomized, double-blind trial [texto impreso] / John Grabowski, Autor ; Howard Rhoades, Autor ; Peter Silverman, Autor . - 2023 . - pp. 305-310. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2000 - Vol. 20 - No. 3 (Junio) . - pp. 305-310 Palabras clave: Cocaína, Trastornos relacionados con la cocaína, Antagonistas de la dopamina, Abandono de pacientes, Psicoterapia, Risperidona. Resumen: A partial blockade of the multiple actions of cocaine is one strategy by which cocaine dependence may be treated. Risperidone, a 5-hydroxytryptamine and dopamine D2 antagonist, is an atypical antipsychotic and was a candidate medication for the treatment of cocaine dependence. One hundred ninety-three cocaine-dependent subjects were enrolled in a 12-week, randomized, double-blind, placebo-controlled trial. Link: ./index.php?lvl=notice_display&id=31196

---

1 (1 - 2 / 2)